Skip to main content

and
  1. No Access

    Article

    Effectiveness and safety of oral extended-release oxymorphone for the treatment of cancer pain: a pilot study

    Inadequate analgesia and/or unmanageable adverse events frequently result in the need to rotate patients with cancer pain to a different opioid. The availability of a novel oral extended-release (ER) formulati...

    Paul Sloan, Neal Slatkin, Harry Ahdieh in Supportive Care in Cancer (2005)